The urine test, called MyProstateScore 2.0, or MPS2, looks at 18 different genes linked to high-grade prostate cancer. The researchers had previously demonstrated that the test was effective in ...
The urine test, called MyProstateScore 2.0, or MPS2, looks at 18 different genes linked to high-grade prostate cancer. The researchers had previously demonstrated that the test was effective in ...
Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies.However, in addition to being uncomfortable, some of these ...
Genomic tests are revolutionizing prostate cancer care, enabling precise, personalized treatment tailored to each patient.
In an interview with Peers & Perspectives in Oncology, Michael S. Leapman, MD, MHS, discusses the significance of a 10-year ...
A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests — Decipher, Oncotype DX Genomic ...
A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests - Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris - can help doctors make better decisions ...
Tissue-based genomic classifier tests, developed to improve prostate cancer risk assessment and treatment recommendations, ...
A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests — Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris — can help doctors make better decisions ...
Biopsy confirmed Gleason grade 7 prostate cancer. Elastography images are courtesy of Dennis Cochlin, University Hospital of Wales, UK and published with permission from Toshiba Medical Systems ...
Explore the role of the extracellular matrix (ECM) in prostate cancer progression and discover natural therapies, including milk thistle, turmeric, and green tea, that target the tumor ...
In a population of patients with initial PSA levels less then 3.0 ng/ml, 21% had prostate cancer on biopsy; 46 of these men, 20.6% had Gleason score 7 or higher disease and 4.7% had Gleason score ...